Experiments by nature: Lessons on type 1 diabetes

Tissue Antigens

Volumn 83, Issue 1, 2014, Pages 1-9

  Battaglia, M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Autoantibodies; Autoimmunity; Dogmas; T cell mediated responses; Type 1 diabetes

Indexed keywords

ADENOSINE DEAMINASE; ALPHA INTERFERON; B LYMPHOCYTE RECEPTOR; GLUTAMATE DECARBOXYLASE 65; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 27; INTERLEUKIN 9; MESSENGER RNA; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3;

ALLELE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; GENE LOCUS; HUMAN; HYPERGLYCEMIA; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VARIABLE NUMBER OF TANDEM REPEAT; VIRUS INFECTION;

AUTOANTIBODIES; AUTOIMMUNITY; DOGMAS; T CELL-MEDIATED RESPONSES; TYPE 1 DIABETES;

AUTOANTIBODIES; AUTOANTIGENS; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84890653791     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12280     Document Type: Review

References (49)

1. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993: 14: 426-30.
2. Pietropaolo M, Towns R, Eisenbarth GS. Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes. Cold Spring Harb Perspect Med 2012: 2: 1-18.
3. Leslie RD. Predicting adult-onset autoimmune diabetes: clarity from complexity. Diabetes 2010: 59: 330-1.
4. Skog O, Korsgren S, Melhus A, Korsgren O. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease. Curr Opin Endocrinol Diabetes Obes 2013: 20: 118-23.
5. Lampeter EF, Homberg M, Quabeck K et al. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 1993: 341: 1243-4.
6. Lampeter EF, McCann SR, Kolb H. Transfer of diabetes type 1 by bone-marrow transplantation. Lancet 1998: 351: 568-9.
7. Couri CE, Oliveira MC, Stracieri AB et al. C-peptide levels and insulin independence following autologous non-myeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2009: 301: 1573-9.
8. Couri CE, Voltarelli JC. Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials. Diabetol Metab Syndr 2009: 1: 19.
9. Frier BM, Saunders JH, Wormsley KG, Bouchier IA. Exocrine pancreatic function in juvenile-onset diabetes mellitus. Gut 1976: 17: 685-91.
10. Perczak-Dudkowska B, Niewiedziol B. Exocrine function of the pancreas in juvenile onset diabetes mellitus. I. pH, duodenal content volume and bicarbonate concentration and secretion. Pediatr Pol 1984: 59: 605-12.
11. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965: 14: 619-33.
12. Hardt PD, Ewald N. Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? Exp Diabetes Res 2011: 2011: 761950.
13. Drell DW, Notkins AL. Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987: 30: 132-43.
14. Creutzfeldt W, Gleichmann D, Otto J, Stockmann F, Maisonneuve P, Lankisch PG. Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion 2005: 72: 71-5.
15. Gaglia JL, Guimaraes AR, Harisinghani M et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest 2011: 121: 442-5.
16. Campbell-Thompson M, Wasserfall C, Montgomery EL, Atkinson MA, Kaddis JS. Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes. JAMA 2012: 308: 2337-9.
17. Valle A, Giamporcaro GM, Scavini M et al. Reduced circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes 2013: 62: 2072-2077.
18. Korsgren S, Molin Y, Salmela K, Lundgren T, Melhus A, Korsgren O. On the etiology of type 1 diabetes: a new animal model signifying a decisive role for bacteria eliciting an adverse innate immunity response. Am J Pathol 2012: 181: 1735-48.
19. Galleri L, Sebastiani G, Vendrame F, Grieco FA, Spagnuolo I, Dotta F. Viral infections and diabetes. Adv Exp Med Biol 2012: 771: 252-71.
20. Coppieters KT, Wiberg A, von Herrath MG. Viral infections and molecular mimicry in type 1 diabetes. APMIS 2012: 120: 941-9.
21. Honeyman M. How robust is the evidence for viruses in the induction of type 1 diabetes? Curr Opin Immunol 2005: 17: 616-23.
22. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011: 342: d35.
23. Clements GB, Galbraith DN, Taylor KW. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995: 346: 221-3.
24. Fuchtenbusch M, Irnstetter A, Jager G, Ziegler AG. No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun 2001: 17: 333-40.
25. Graves PM, Rotbart HA, Nix WA et al. Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). Diabetes Res Clin Pract 2003: 59: 51-61.
26. Stechova K, Halbhuber Z, Hubackova M et al. Case report: type 1 diabetes in monozygotic quadruplets. Eur J Hum Genet 2012: 20: 457-62.
27. Murugaiyan G, Mittal A, Lopez-Diego R, Maier LM, Anderson DE, Weiner HL. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 2009: 183: 2435-43.
28. Nowak EC, Weaver CT, Turner H et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 2009: 206: 1653-60.
29. Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005: 435: 590-7.
30. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007: 7: 585-98.
31. Pugliese A, Zeller M, Fernandez A Jr et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997: 15: 293-7.
32. De Martino L, Capalbo D, Improda N et al. APECED: a paradigm of complex interactions between genetic background and susceptibility factors. Front Immunol 2013: 4: 331.
33. Cai CQ, Zhang T, Breslin MB, Giraud M, Lan MS. Both polymorphic variable number of tandem repeats and autoimmune regulator modulate differential expression of insulin in human thymic epithelial cells. Diabetes 2011: 60: 336-44.
34. Turunen JA, Wessman M, Forsblom C et al. Association analysis of the AIRE and insulin genes in Finnish type 1 diabetic patients. Immunogenetics 2006: 58: 331-8.
35. Ward L, Paquette J, Seidman E et al. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab 1999: 84: 844-52.
36. Paquette J, Varin DS, Hamelin CE et al. Risk of autoimmune diabetes in APECED: association with short alleles of the 5'insulin VNTR. Genes Immun 2010: 11: 590-7.
37. Gylling M, Tuomi T, Bjorses P et al. ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2000: 85: 4434-40.
38. Barzaghi F, Passerini L, Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol 2012: 3: 211.
39. Gambineri E, Perroni L, Passerini L et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol 2008: 122: 1105-12.e1.
40. Rubio-Cabezas O, Minton JA, Caswell R et al. Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes. Diabetes Care 2009: 32: 111-6.
41. Scaillon M, Van Biervliet S, Bontems P et al. Severe gastritis in an insulin-dependent child with an IPEX syndrome. J Pediatr Gastroenterol Nutr 2009: 49: 368-70.
42. Bacchetta R, Passerini L, Gambineri E et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006: 116: 1713-22.
43. Culina S, Mallone R. Pathogenic and regulatory T cells in type 1 diabetes: losing self-control, restoring it, and how to take the temperature. Curr Diab Rep 2011: 11: 426-33.
44. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009: 361: 2143-52.
45. Pescovitz MD, Greenbaum CJ, Bundy B et al. B-lymphocyte depletion with rituximab and beta-cell function: two-year results. Diabetes Care 2013 Epub ahead of print.
46. Pozzilli P, Buzzetti R, Dotta F, Andreani D. Acute onset of seeming IDDM in an AIDS patient. Diabetes Care 1992: 15: 1824-5.
47. Notarangelo LD, Stoppoloni G, Toraldo R et al. Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency. Eur J Pediatr 1992: 151: 811-4.
48. Sauer AV, Brigida I, Carriglio N, Aiuti A. Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency. Front Immunol 2012: 3: 265.
49. Martin S, Wolf-Eichbaum D, Duinkerken G et al. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 2001: 345: 1036-40.